Skip to main content
. 2020 Aug 25;15:6409–6420. doi: 10.2147/IJN.S246659

Figure 6.

Figure 6

Side effects in liver and kidney by MP, PTX and MP-PTX. (A) Creatinine level in peripheral blood. (B) Glutamic-pyruvic aminotransferase level in peripheral blood. The toxicity of MP-PTX to liver and kidney was similar as control group, but the toxicity of PTX to liver and kidney was higher than control group. The toxicity of MP-PTX to liver and kidney was reduced compared to that PTX alone (*P < 0.05).